UK's First MS Patient Trials Groundbreaking 'Gamechanger' Treatment
TL;DR Summary
A Hertfordshire mother and biology teacher, Emily Henders, has become the first UK patient to receive a pioneering CAR T cell therapy in a clinical trial aimed at treating multiple sclerosis, a disease that causes immune system attacks on nerves. The experimental treatment, which depletes B cells to reset the immune system, offers hope for slowing or halting disease progression and could be a gamechanger if successful.
Topics:health#autoimmune-disease#car-t-cell-therapy#clinical-trial#health#hertfordshire#ms-treatment
- Hertfordshire mum is first UK patient to trial new MS treatment BBC
- Biology teacher becomes first UK patient to receive ‘gamechanger’ therapy for MS The Independent
- Woman has new multiple sclerosis treatment that doctors say could be 'game-changer' Sky News
- ‘Gamechanger’ treatment could halt the progression of MS inkl
- First multiple sclerosis patient in the UK receives CAR T cell therapy in groundbreaking trial News-Medical
Reading Insights
Total Reads
0
Unique Readers
2
Time Saved
3 min
vs 4 min read
Condensed
89%
630 → 67 words
Want the full story? Read the original article
Read on BBC